+141.0%
DRUG vs VOO
+110.6%
+30.4%
-97.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | VOO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.8% | -0.5% | -2.3% | -2.7% |
| 7D | -8.5% | -0.4% | -8.2% | -8.5% |
| 30D | -19.5% | -1.4% | -18.1% | -19.2% |
| 3M | -4.0% | +3.7% | -7.8% | -4.7% |
| 6M | -19.1% | +13.0% | -32.2% | -20.9% |
| YTD | -16.6% | +12.4% | -29.1% | -18.4% |
| 1Y | +54.3% | +18.6% | +35.7% | +50.6% |
| 3Y | +3,288.5% | +78.1% | +3,210.5% | +2,518.4% |
| 5Y | +133.7% | +82.3% | +51.4% | +75.7% |
| All | +141.0% | +110.6% | +30.4% | +138.6% |
Cumulative growth
Daily Returns
Daily percentage return beside VOO.
Daily Out/Under-Performance
Portfolio return minus VOO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VOO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded VOO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling